Cologuard Screening Interval After Negative Result
No, if Cologuard results are negative, you should repeat the test in 3 years, not 1 year.
Recommended Screening Interval
The appropriate interval for repeating Cologuard (multitarget stool DNA test) after a negative result is every 3 years 1. This is the standard recommendation from the U.S. Multi-Society Task Force on Colorectal Cancer, which classifies Cologuard as a second-tier screening test.
Key Evidence and Rationale
FDA Approval and Guidelines
- Cologuard was FDA-approved in August 2014 as a primary screening modality for colorectal cancer 2
- The test demonstrated 92.3% sensitivity for detecting colorectal cancer and 42.4% sensitivity for advanced precancerous lesions 2
- The 3-year interval is based on the test's performance characteristics and the natural history of colorectal cancer progression 1
Important Caveats
Limited evidence exists for optimal screening intervals. The 2015 NCCN Guidelines specifically noted that "an appropriate screening interval cannot be recommended at this time because of limited available data," and therefore initially did not recommend stool DNA testing as a primary screening modality 2. However, subsequent consensus recommendations have settled on the 3-year interval 1.
Comparison to Other Screening Tests
For context, other screening intervals include:
- FIT (Fecal Immunochemical Test): Annually 1
- Colonoscopy: Every 10 years (if negative) 1
- CT colonography: Every 5 years 1
The 3-year interval for Cologuard represents a middle ground, reflecting its higher single-test sensitivity compared to FIT but lower specificity (86.6% vs. 96% for FIT alone) 3.
Clinical Considerations
Specificity decreases with age. The test's specificity drops to only 83% in persons aged >65 years, meaning more false positives in older adults 3. This is an important consideration when counseling patients about expected follow-up colonoscopy rates.
Cost implications matter. At approximately $500-600 per test, Cologuard costs about 10 times more than annual FIT, with additional costs from higher colonoscopy referral rates due to lower specificity 3.
The test is particularly appropriate for patients aged 50-65 years who seek a noninvasive test with very high cancer sensitivity, as specificity is better in this age group 3.
What NOT to Do
- Do not repeat in 1 year unless there are new symptoms or other clinical indications
- Do not perform interval FIT testing between scheduled Cologuard tests if the patient is adherent to the 3-year screening schedule
- Do not use Cologuard as an annual screening test - this is not supported by evidence and would be cost-prohibitive